4
Changes in Ownership
Bausch Health Companies Inc. Filed Acc 0000899243-22-008822
U.S. President-Pharma Business gave up 8,925 shares (to pay taxes)
- U.S. President-Pharma Business acquired 15,615 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Spurr Robert U.S. President-Pharma Business | 2022-02-27 | Option exercise | +15,615 | 75,914 | D: show line 1 in the form | ||
| Spurr Robert U.S. President-Pharma Business | 2022-02-27 | Shares withheld for taxes | −5,646 | $24.35 | $137,480 | 70,268 | D: show line 2 in the form |
| Spurr Robert U.S. President-Pharma Business | 2022-02-26 | Shares withheld for taxes | −1,628 | $24.35 | $39,642 | 68,640 | D: show line 3 in the form |
| Spurr Robert U.S. President-Pharma Business | 2022-02-27 | Shares withheld for taxes | −1,651 | $24.35 | $40,202 | 66,989 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Spurr Robert U.S. President-Pharma Business | 2022-02-27 | Grant or award · Restricted Share Units | +15,615 | 0 | D: show line 5 in the form | |||||
| Spurr Robert U.S. President-Pharma Business | 2022-02-27 | Option exercise · Restricted Share Units | −15,615 | $24.35 | $380,225 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…